Q32 Bio (QTTB) Shares Outstanding (Weighted Average) (2017 - 2026)

Q32 Bio's Shares Outstanding (Weighted Average) history runs 10 years deep, the most recent figure standing at $14.1 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) rose 15.56% year-over-year to $14.1 million; the TTM figure through Mar 2026 stood at $14.1 million (up 15.56% YoY), while the FY2025 annual figure was $12.3 million, up 31.97% from the prior year.
• Shares Outstanding (Weighted Average) was $14.1 million for Q1 2026 at Q32 Bio, up from $12.3 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $57.4 million in Q3 2022 to a low of $344623.0 in Q1 2023.
• Historically, Shares Outstanding (Weighted Average) has averaged $19.0 million across 5 years, with a median of $12.2 million in 2025.
• The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Weighted Average) plunged 99.4% in 2023, then soared 3387.39% in 2024.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $57.4 million in 2022, then tumbled by 99.39% to $349060.0 in 2023, then jumped by 2570.28% to $9.3 million in 2024, then soared by 31.97% to $12.3 million in 2025, then gained by 14.59% to $14.1 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $14.1 million (Q1 2026), $12.3 million (Q4 2025), and $12.2 million (Q3 2025), per Business Quant data.